Coronavirus: Vaccination

(asked on 8th February 2021) - View Source

Question to the Foreign, Commonwealth & Development Office:

To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, what recent steps he has taken to meet the previous Business Secretary's statement of 14 August 2020 that the UK's Janssen and Novavax agreements will ensure fair and equitable access of a vaccine around the world.


Answered by
Wendy Morton Portrait
Wendy Morton
This question was answered on 11th February 2021

The UK is committed to rapid equitable access to safe and effective vaccines, as shown through its commitment of £548 million to the COVAX Advance Market Commitment (AMC). Our commitment will contribute to the supply of at least 1.3 billion doses of COVID-19 vaccines in 2021 for up to 92 developing countries. Deliveries are expected to begin soon.

The vaccine candidates developed by Janssen and Novavax are both part of the COVAX portfolio. Subject to their approval by stringent regulatory bodies, they will both contribute to doses delivered in developing countries. We welcome Janssen's vaccine being made available on a not-for-profit basis during the pandemic, and Novavax's agreement with the Serum Institute of India to produce its vaccine candidate for COVAX. These will both help ensure global supply and the equitable access of vaccines.

Reticulating Splines